Abstract
Despite advances in the prevention and treatment of end-stage organ failure, solid-organ transplantation remains for many the best option for improving the quality of life and the likelihood of survival. Procurement of organs from brain-dead donors is the only option for the majority of patients with end-stage heart and lung failure needing and qualifying for transplantation. It has been known for quite some time, however, that the brain death process can lead to a pathophysiologic cascade that potentially produces significant donor organ dysfunction. As a result, a significant effort has been made to explore approaches to improve donor organ function by removing the organ from the brain death milieu and by protecting the organs in vivo and ex vivo from the cascade of events that is initiated during the brain death process and the inevitable and obligatory ischemia–reperfusion event. This chapter summarizes some of the exciting approaches ranging from attempts at improving the logistics of donor procurement to controlling the molecular events that lead to organ dysfunction. Thankfully, the altruism of truly generous families and donors offers hope to many.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jendrisak MD, Hruska K, Wagner J, Chandler D, Kappel D. Cadaveric-donor organ recovery at a hospital-independent facility. Transplantation. 2002;74:978–82.
Conte JV, Baumgartner WA. Commentary on Cadaveric-donor organ recovery at a hospital-independent facility. Transplantation. 2002;74:931–2.
Jendrisak MD, Hruska K, Wagner J, Chandler D, Kappel D. Hospital-independent organ recovery from deceased donors: a two-year experience. Am J Transplant. 2005;5:1105–11110.
Moazami N, Javadi OH, Kappel DF, Wagner J, Jendrisak MD. The feasibility of organ procurement at a hospital-independent facility: a working model of efficiency. J Thorac Cardiovasc Surg. 2007;133: 1389–90.
Billingham ME, Baumgartner WA, Watson DC, et al. Distant heart procurement for human transplantation. Ultrastructural studies. Circulation. 1980;62:I11–9.
Watson DC, Reitz BA, Baumgartner WA, et al. Distant heart procurement for transplantation. Surgery. 1979;86:56–9.
St Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion. Lancet. 2002;359:604–13.
Collins MJ, Moainie SL, Griffith BP, Poston RS. Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool. Eur J Cardiothorac Surg. 2008;34:318–25.
Wicomb WN, Cooper DK, Novitzky D, Barnard CN. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. Ann Thorac Surg. 1984;37:243–8.
Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357:825–9.
Steen S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjoberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg. 2003;76:244–52.
Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83:2191–4.
Cypel M, Liu M, Rubacha M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med. 2009;1:4ra9.
Hardy JD, Eraslan S, Webb WR. Transplantation of the lung. Ann Surg. 1964;160:440–8.
Allan JS. Invited commentary. Ann Thorac Surg. 2007;83:2194–5.
Wilkes DS. A breath of fresh air for lung transplant recipients. Sci Transl Med 2009;1:4ps5.
Bashyam H. Th1/Th2 cross-regulation and the discovery of IL-10. J Exp Med. 2007;204:237.
Izant JG, Weintraub H. Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell. 1984;36:1007–15.
Sen GL, Blau HM. A brief history of RNAi: the silence of the genes. FASEB J. 2006;20:1293–9.
Romano N, Macino G. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol. 1992;6:3343–53.
Guo S, Kemphues KJ. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell. 1995;81:611–20.
Napoli C, Lemieux C, Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell. 1990;2:279–89.
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–11.
Dykxhoorn DM, Palliser D, Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther. 2006;13:541–52.
Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science. 1999;286:950–2.
Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 2000;101:25–33.
Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001;409:363–6.
Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 2000;404: 293–6.
Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell. 2003;115:209–16.
Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol. 2003;14: 128–38.
Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The nympathetic nerve-an Integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595–638.
van Westerloo DJ, Giebelen IA, Florquin S, et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis. 2005;191:2138–48.
Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Intern Med. 2005;257:156–66.
Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289–96.
Hoeger S, Bergstraesser C, Selhorst J, et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant. 2010;10:477–89.
Acknowledgments
The authors wish to thank Ms. Shree Smith and Ms. Laurie Dean for their assistance in preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pajaro, O.E., Kirklin, J.K. (2013). Current and Potential Future Trends in the Management of the Brain-Dead Organ Donor. In: Novitzky, D., Cooper, D. (eds) The Brain-Dead Organ Donor. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4304-9_27
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4304-9_27
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4303-2
Online ISBN: 978-1-4614-4304-9
eBook Packages: MedicineMedicine (R0)